Actions & Insights Evaluating a Novel Diabetes Management Solution

CompletedOBSERVATIONAL

Enrollment

163

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions

Diabetes Mellitus ( Type 1 and Type 2)

Trial Locations (3)

Birmingham Heartlands Hospital, Birmingham

Royal Infirmary of Edinburgh, Edinburgh

Highland Clinical Research Facility, Inverness

All Listed Sponsors

lead

LifeScan Scotland Ltd

INDUSTRY

NCT03638349 - Actions & Insights Evaluating a Novel Diabetes Management Solution | Biotech Hunter | Biotech Hunter